A Pooled Analysis From Phase 2b and 3 Studies in Japan of Istradefylline in Parkinson's Disease

BACKGROUND: Characterization of patient factors associated with istradefylline efficacy may facilitate personally optimized treatment. OBJECTIVES: We aimed to examine which patient factors are associated with favorable istradefylline treatment outcomes in PD patients with motor complications. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Nobutaka, Kitabayashi, Hiroki, Kanda, Tomoyuki, Nomura, Takanobu, Toyama, Keizo, Mori, Akihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496465/
https://www.ncbi.nlm.nih.gov/pubmed/32501582
http://dx.doi.org/10.1002/mds.28095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496465/
https://www.ncbi.nlm.nih.gov/pubmed/32501582
http://dx.doi.org/10.1002/mds.28095

Ejemplares similares